BiologicalDrug
Gla-af clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2011
How studies write it
Studies that test it under each name
Name
Studies by the year they started
3 studies that test it; most in 2011 (1)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
Who runs them
Industry 0 · Other 3
Imperial College London (1) · Access to Advanced Health Institute (AAHI) (1) · Rockefeller University (1)
Often tested with
Tested in the same studies.
TLR4 Agonist G100 (2) · EM060G (1)
Studies
Open first, then newest update. How each study uses gla-af is read from its arms, and is right about nine times in ten.
Testing it · 3
- Investigating Immunisation Strategies of DNA, MVA and CN54rgp140 Adjuvanted With GLA-AF to Maximise Antibody ResponsesCompletedPhase 1Imperial College LondonNCT01922284Written as GLA-AF
- The Effects of GLA (5 mcg) on Human VolunteersCompletedPhase 1Access to Advanced Health Institute (AAHI)NCT01864876Written as GLA-AF
- The Effects of GLA on Human VolunteersCompletedPhase 1Rockefeller UniversityNCT01397604Written as GLA-AF
Given in every arm · 2 — gla-af is usual care beside what is tested
- A Phase Ib Study of the Safety, Reactogenicity, and Immunogenicity of Sm-TSP-2/Alhydrogel)(R) With or Without AP 10-701 for Intestinal Schistosomiasis in Healthy Exposed AdultsCompletedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT03110757Written as GLA-AF
- Safety and Immunogenicity of the Na-APR-1 Hookworm Vaccine in Healthy AdultsCompletedPhase 1Baylor College of MedicineNCT01717950Written as Gluco-Pyranosylphospho-Lipid A Aqueous Formulation